LONGMONT, Colo.--(BUSINESS WIRE)--nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, today announced that 2011 earnings before interest and taxes were up 40% when compared to 2010. “Total year sales of $27.8M were up slightly year over year with sales in our higher margin services business up 9%. This was partially offset by a decline in the product based businesses principally in Europe. The Company is profitable and our balance sheet remains strong with net assets up 11% and no debt,” said David Jackson Executive Vice President and CFO.
